secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0001641172-25-011246
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix raises $10M in public offering of Series G preferred and warrants
------------------------------------------------------------------------------

- Gross proceeds ~$10M from 400,000 Series G convertible preferred shares at $25/share, each with a warrant to buy 4.9M common shares at $2.04.
- Preferred pays 9% cumulative dividend, convertible at $2.04/share, subject to full-ratchet anti-dilution and 4.99%/9.99% beneficial ownership cap.
- Use of proceeds: repay $1.3M debenture (Feb 2025) and up to $700k on $2.5M note (Jan 2025); remainder for general corporate purposes.
- Amended Series X preferred: increased authorized shares from 57,720 to 62,220 and cut conversion price to match Series G price.
- Dawson James Securities acted as sole bookrunner; offering closed May 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225011246/0001641172-25-011246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225011246/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer